A case of primary erythromelalgia improved by mexiletine [2]

British Journal of Dermatology

Volumn 151, Issue 3, 2004, Pages 708-710

  Jang, H S ^a   Jung, D ^a   Kim, S ^a   Jo, J ^a   Lee, J ^a   Kim, M ^a   Oh, C ^a   Kwon, K ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LIDOCAINE; MEXILETINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PROPRANOLOL; SEROTONIN ANTAGONIST; SERTRALINE; SODIUM CHANNEL BLOCKING AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ANTINOCICEPTION; BLISTER; CASE REPORT; CLINICAL FEATURE; CRYOTHERAPY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; ERYTHEMA; ERYTHROMELALGIA; FOOT PAIN; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFRARED PHOTOGRAPHY; LEG EDEMA; LEG PAIN; LETTER; MALE; NAUSEA; OUTCOMES RESEARCH; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; STOMACH PAIN; SYMPTOM; VISUAL ANALOG SCALE; VOMITING; XEROSTOMIA;

ADULT; DERMATOLOGIC AGENTS; ERYTHROMELALGIA; HUMANS; LEG DERMATOSES; MALE; MEXILETINE;

EID: 4944239130     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06167.x     Document Type: Letter

References (10)

1. Smith LA, Allen EV. Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat and pain. Am Heart J 1938; 16: 175-88.
2. Kvernebo K. Erythromelalgia - a disease caused by arteriovenous shunting. Vasa 1998; 1: 1-39.
3. Mork C, Kvernebo K. Erythromelalgia - a mysterious condition? Arch Dermatol 2000; 136: 406-9.
4. Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop 1979; 144: 249-54.
5. Davis MD, O'Fallon WM, Rogers RS III et al. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol 2000; 136: 330-6.
6. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 2000; 43: 841-7.
7. Jarvis B, Coukell AJ. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 1998; 56: 691-707.
8. Kuhnert SM, Phillips WJ, Davis MD. Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol 1999; 135: 1447-9.
9. Mork C, Kalgaard OM, Kvernebo K. Impaired neurogenic control of skin perfusion in erythromelalgia. J Invest Dermatol 2002; 118: 699-703.
10. Sandroni P, Davis MD, Harper CM Jr. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuse Dis 1999; 1: 57-63.